Astria Therapeutics, Inc. — Net Income by Fiscal Year
12 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/8318be18-13b0-400a-bc4f-3298050a102c/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2024 | $-94.3M | 2024-01-01 – 2024-12-31 | evidence 0001410578-25-000309 |
| FY 2023 | $-72.9M | 2023-01-01 – 2023-12-31 | evidence 0001410578-24-000127 |
| FY 2022 | $-51.8M | 2022-01-01 – 2022-12-31 | evidence 0001104659-23-035584 |
| FY 2021 | $-194.9M | 2021-01-01 – 2021-12-31 | evidence 0001104659-22-032475 |
| FY 2020 | $-37.3M | 2020-01-01 – 2020-12-31 | evidence 0001104659-21-051616 |
| FY 2019 | $-26.3M | 2019-01-01 – 2019-12-31 | evidence 0001047469-20-001338 |
| FY 2018 | $-25.9M | 2018-01-01 – 2018-12-31 | evidence 0001047469-19-001212 |
| FY 2017 | $-27.4M | 2017-01-01 – 2017-12-31 | evidence 0001047469-18-001688 |
| FY 2016 | $-36.1M | 2016-01-01 – 2016-12-31 | evidence 0001047469-17-001682 |
| FY 2015 | $-32.6M | 2015-01-01 – 2015-12-31 | evidence 0001047469-16-011175 |
| FY 2014 | $-21.9M | 2014-01-01 – 2014-12-31 | evidence 0001047469-16-011175 |
| FY 2013 | $-18.1M | 2013-01-01 – 2013-12-31 | evidence 0001047469-16-011175 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Astria Therapeutics, Inc. — all facts · Revenue · Operating Income